Peregrine Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-301,068	Closed	-$1.84M	–	326
2023 Q1	$1.84M	Buy	301,068 +8,903	+3%	+$61.4K	0.05%	246
2022 Q4	$1.87M	Buy	292,165 +50,671	+21%	+$396K	0.06%	242
2022 Q3	$2.31M	Sell	241,494 -13,318	-5%	-$154K	0.07%	244
2022 Q2	$2.81M	Sell	254,812 -2,964	-1%	-$38.8K	0.08%	248
2022 Q1	$4.29M	Buy	257,776 +5,926	+2%	+$91.6K	0.1%	249
2021 Q4	$4.81M	Buy	251,850 +46,016	+22%	+$1.01M	0.1%	248
2021 Q3	$5.08M	Sell	205,834 -40,748	-17%	-$960K	0.11%	247
2021 Q2	$6.42M	Buy	246,582 +10,398	+4%	+$270K	0.12%	255
2021 Q1	$7.48M	Sell	236,184 -33,045	-12%	-$1.37M	0.14%	250
2020 Q4	$12.5M	Sell	269,229 -101,839	-27%	-$4.04M	0.24%	204
2020 Q3	$12.2M	Sell	371,068 -35,333	-9%	-$1.08M	0.32%	115
2020 Q2	$11.2M	Buy	406,401 +26,983	+7%	+$887K	0.32%	121
2020 Q1	$11.4M	Sell	379,418 -162,558	-30%	-$4.31M	0.41%	105
2019 Q4	$15M	Sell	541,976 -101,439	-16%	-$2.31M	0.38%	116
2019 Q3	$11.7M	Sell	643,415 -14,236	-2%	-$315K	0.32%	127
2019 Q2	$16.1M	Sell	657,651 -173,864	-21%	-$2.62M	0.4%	109
2019 Q1	$7.91M	Buy	+831,515	New	+$8.08M	0.2%	203